Mark Sostek
AstraZeneca
4
0
4
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Alshimaa azab, PhD
Cairo University
Shared therapeutic areas:
Marinka Twilt, MD MSCE PhD
University of Calgary / Alberta Children's Hospital
Shared therapeutic areas:
Ragab K. Elnaggar, PhD
Prince Sattam Bin Abdulaziz University
Shared therapeutic areas:
Dana Anaby, PhD
McGill University
Shared therapeutic areas:
Bruce Berger, MD
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Shared therapeutic areas:
Heinrike Schmeling, MD
Alberta Children's Hospital
Shared therapeutic areas:
Etienne Merlin
University Hospital, Clermont-Ferrand
Shared therapeutic areas:
Andrew Davies, MD
Royal Surrey County Hospital NHS Foundation Trust
Shared therapeutic areas:
Hadas Nahman-Averbuch, PhD
Washington University School of Medicine
Shared therapeutic areas:
Lindsey Mathew
Bausch Health Companies
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
Assessment of Pharmacokinetics of a Single Oral Dose of VIMOVO in Healthy Adult Volunteers
A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation
All 4 trials loaded